Cambiar Investors LLC Has $9.21 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cambiar Investors LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 340,234 shares of the medical instruments supplier’s stock after buying an additional 10,862 shares during the quarter. Cambiar Investors LLC owned approximately 0.17% of DENTSPLY SIRONA worth $9,207,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in XRAY. First Eagle Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 33.6% during the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares during the last quarter. Nuance Investments LLC raised its position in DENTSPLY SIRONA by 3.8% during the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after purchasing an additional 402,329 shares during the last quarter. Cooke & Bieler LP lifted its holdings in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after buying an additional 1,046,105 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after buying an additional 343,915 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after buying an additional 1,308,411 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on XRAY shares. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Evercore ISI dropped their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Barrington Research reiterated an “outperform” rating and set a $36.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Monday, October 28th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $32.67.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $23.49 on Friday. The business has a 50-day simple moving average of $25.12 and a 200 day simple moving average of $26.27. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA Inc. has a one year low of $22.85 and a one year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same period in the previous year, the company earned $0.51 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% compared to the same quarter last year. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.